AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 177 filers reported holding AXSOME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217 | +112.7% | 3,112 | +120.4% | 0.00% | – |
| Q2 2023 | $102 | +7.4% | 1,412 | -8.4% | 0.00% | – |
| Q1 2023 | $95 | -20.2% | 1,541 | 0.0% | 0.00% | – |
| Q4 2022 | $119 | -99.8% | 1,541 | 0.0% | 0.00% | – |
| Q3 2022 | $69,000 | +16.9% | 1,541 | 0.0% | 0.00% | – |
| Q2 2022 | $59,000 | -13.2% | 1,541 | 0.0% | 0.00% | – |
| Q1 2022 | $68,000 | +17.2% | 1,541 | 0.0% | 0.00% | – |
| Q4 2021 | $58,000 | +13.7% | 1,541 | 0.0% | 0.00% | – |
| Q3 2021 | $51,000 | -51.0% | 1,541 | 0.0% | 0.00% | – |
| Q2 2021 | $104,000 | -9.6% | 1,541 | -25.0% | 0.00% | – |
| Q1 2021 | $115,000 | -31.1% | 2,055 | 0.0% | 0.00% | – |
| Q4 2020 | $167,000 | +14.4% | 2,055 | 0.0% | 0.00% | – |
| Q3 2020 | $146,000 | -13.1% | 2,055 | 0.0% | 0.00% | – |
| Q2 2020 | $168,000 | +75.0% | 2,055 | +27.6% | 0.00% | – |
| Q1 2020 | $96,000 | -41.8% | 1,610 | 0.0% | 0.00% | – |
| Q4 2019 | $165,000 | +111.5% | 1,610 | -47.0% | 0.00% | – |
| Q2 2019 | $78,000 | – | 3,035 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |